Skip directly to content

Прегабалин рекомендован для лечения нейропатической боли согласно международным рекомендациям

  1. Dworkin R. H., et al. Recommendations for the Pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010; 85 (Suppl 3): S 3–14.
  2. Attal N., et al. EFNS guidelines on the pharmacological treatment on neuropathic pain: 2009 revision. Eur J Neurol. 2010; 17 (9): 1113–e88.
  3. Jost L., Roila F. Management of cancer pain: ESMO Clinical practice Guidelines. Ann Oncol. 2010; 21 (Suppl 5): v257–v260.
  4. Bril V., et al. Evidence-based guildeline. Neurology. 2011; 76: 1–8.
  5. Методические рекомендации по диагностике и лечению невропатической боли. Под ред. Н. Н. Яхно. М.: Издательство РАМН, 2008. С. 15–19; 23.
  6. Moulin D. E., et al. Pharmacological management of chronic neuropathic pain – consensus statement and guidelines from the Canadian pain society. Pain Res Manag. 2007; 12 (1): 13–21.
  7. CREST. Guidelines on the management of neuropathic pain. Available at:
  8. Martinez V., et al. Chronic neuropathic pain: diagnosis, evaluation and treatment in outpatient services. Guidelines for clinical practice of the French Society for the Study and treatment of pain. Douleurs. 2010; 11: 3–21.
  9. Rowbotham M. et al. Pregabalin shows reduction in pain by day three of treatment: analysis of daily pain scores. Poster presented at APS, 2003.
  10. D’Urso de Cruz et al. Long-term treatment of painful DPN and PHN with pregabalin in treatment-refractory patients. Poster presented at APS, 2005.
  11. Portenoy R. et al. Onset and duration of analgesia in combined Analyses of Clinical Trials of Pregabalin for Painful DPN and PHN. Poster presented at the 25th Annual Scientific Meeting of the American Pain Society; 3-6 May 2006; San Antonio, Texas.